Fujiyoshi Naoki, Ushijima Kimio, Kawano Kouichiro, Fujiyoshi Keizo, Yamaguchi Tomohiko, Araki Yuko, Kakuma Tatsuyuki, Watanabe Sumiko, Kaku Tsunehisa, Nishida Takashi, Kamura Toshiharu
Department of Obstetrics and Gynecology, School of Medicine, Kurume University, Kurume, Fukuoka ; Department of Gynecology, Oita Prefecture Saiseikai Hita Hospital, Hita, Oita.
Department of Obstetrics and Gynecology, School of Medicine, Kurume University, Kurume, Fukuoka.
Mol Clin Oncol. 2015 Jan;3(1):51-54. doi: 10.3892/mco.2014.413. Epub 2014 Sep 9.
Since uterine cervical cancer is regarded as a radiosensive tumor, ionizing radiation is the most frequently used treatment modality against the disease. Although the crucial end-point is radiation-induced cell death, the tumors are not equally sensitive to radiation. Determining the criteria that may be used to predict tumor radiosensitivity is of importance; however, little success has been achieved thus far. In radioresistant cases the therapeutic strategy should be changed, thereby avoiding ineffective or unnecessary treatment. Furthermore, identification of the underlying molecular processes leading to radioresistance may lead to novel radiosensitising strategies. Cervical smears were obtained from seven patients with locally advanced cervical cancer following each radiotherapy, and the radiation-induced damage of cancer tissue was examined by routine cytology. Since the formation of DNA double-strand breaks is considered critical for the cytocidal effect of radiation therapy, the molecular changes of the neoplastic cells were also assessed by laser scanning cytometry (LSC). Radiation-induced morphological changes of cancer cells were evident at a dose of 7.2 Gy, whereas increased DNA content (or DNA index) was observed prior to the onset of morphological changes. Molecular change was detected earlier than the morphological change of the irradiated cancer cells, indicating the feasibility of LSC in predicting the radiosensitivity of cervical cancer tissue.
由于子宫颈癌被视为一种对辐射敏感的肿瘤,电离辐射是针对该疾病最常用的治疗方式。尽管关键终点是辐射诱导的细胞死亡,但肿瘤对辐射的敏感性并不相同。确定可用于预测肿瘤放射敏感性的标准很重要;然而,迄今为止收效甚微。在放射抵抗的病例中,治疗策略应改变,从而避免无效或不必要的治疗。此外,识别导致放射抵抗的潜在分子过程可能会带来新的放射增敏策略。在每次放射治疗后,从7例局部晚期子宫颈癌患者获取宫颈涂片,并通过常规细胞学检查癌组织的辐射诱导损伤。由于DNA双链断裂的形成被认为对放射治疗的杀细胞作用至关重要,还通过激光扫描细胞术(LSC)评估肿瘤细胞的分子变化。在7.2 Gy的剂量下,癌细胞的辐射诱导形态变化明显,而在形态变化开始之前就观察到DNA含量增加(或DNA指数)。分子变化比受照射癌细胞的形态变化检测得更早,表明LSC在预测子宫颈癌组织放射敏感性方面的可行性。